phosphatidylcholines has been researched along with Peripheral Arterial Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandtner, EM; Dopheide, JF; Drexel, H; Fraunberger, P; Jylhä, A; Kleber, M; Laaksonen, R; Lääperi, M; Leiherer, A; Mader, A; März, W; Mündlein, A; Ramadani, H; Säly, CH; Vonbank, A | 1 |
| Golledge, J; Jones, RE; Kingwell, BA; Meikle, PJ; Mellett, NA; Moxon, JV; Weir, JM; Wong, G | 1 |
| Eha, J; Jakobson, M; Kals, J; Lieberg, J; Ottas, A; Paapstel, K; Piir, A; Tootsi, K; Zilmer, M | 1 |
| Dennis, EA; Hung, MY; Hutchins, PM; Leibundgut, G; Mahmud, E; Miller, YI; Murphy, RC; Patel, M; Prasad, A; Ravandi, A; Tsimikas, S; Witztum, JL | 1 |
| Cheng, XW; Enomoto, H; Goto-Inoue, N; Hayasaka, T; Kuzuya, M; Onoue, K; Sasaki, T; Setou, M; Tanaka, H; Unno, N; Zaima, N | 1 |
5 other study(ies) available for phosphatidylcholines and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference?
Topics: Atherosclerosis; Ceramides; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Lipids; Lipoproteins; Peripheral Arterial Disease; Phosphatidylcholines; Risk Factors | 2021 |
Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations.
Topics: Aged; Area Under Curve; Biomarkers; Chromatography, Liquid; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peripheral Arterial Disease; Phosphatidylcholines; Plasmalogens; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Queensland; Risk Factors; ROC Curve; Tandem Mass Spectrometry; Time Factors | 2017 |
Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis.
Topics: Aged; Angiography, Digital Subtraction; Arginine; Biomarkers; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Endothelium, Vascular; Heart Rate; Humans; Lysophosphatidylcholines; Male; Metabolomics; Middle Aged; Peripheral Arterial Disease; Phosphatidylcholines; Pulse Wave Analysis; Vascular Stiffness | 2018 |
Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.
Topics: Aged; Aged, 80 and over; Catheterization, Peripheral; Cholesterol Esters; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Phosphatidylcholines; Phospholipids; Tandem Mass Spectrometry | 2014 |
Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Calcinosis; Cholesterol Esters; Disease Models, Animal; Humans; Linoleic Acids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peripheral Arterial Disease; Phosphatidylcholines; Predictive Value of Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triglycerides | 2011 |